LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 91 filers reported holding LEGEND BIOTECH CORP in Q3 2021. The put-call ratio across all filers is 0.88 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $756 | -11.2% | 11,246 | -7.0% | 0.00% | 0.0% |
| Q2 2023 | $851 | +46.5% | 12,089 | -0.9% | 0.00% | +100.0% |
| Q1 2023 | $581 | +9.2% | 12,201 | +13.7% | 0.00% | 0.0% |
| Q4 2022 | $532 | -99.9% | 10,734 | -22.4% | 0.00% | -50.0% |
| Q3 2022 | $550,000 | -26.2% | 13,832 | -0.1% | 0.00% | 0.0% |
| Q2 2022 | $745,000 | -63.2% | 13,845 | +11.8% | 0.00% | -60.0% |
| Q1 2022 | $2,022,000 | +384.9% | 12,386 | +40.2% | 0.01% | +400.0% |
| Q4 2021 | $417,000 | +46.8% | 8,835 | +47.2% | 0.00% | 0.0% |
| Q3 2021 | $284,000 | +16.9% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $243,000 | +41.3% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $172,000 | -0.6% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $173,000 | – | 6,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 1,629,173 | $89,605,000 | 22.89% |
| Paradigm Biocapital Advisors LP | 978,596 | $53,823,000 | 10.73% |
| FengHe Fund Management Pte. Ltd. | 475,263 | $26,139,000 | 10.25% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,222,342 | $67,229,000 | 9.65% |
| HHLR ADVISORS, LTD. | 4,436,617 | $244,014,000 | 5.23% |
| Iron Triangle Partners LP | 495,329 | $27,243,000 | 3.53% |
| Parkman Healthcare Partners LLC | 117,807 | $6,479,000 | 2.39% |
| AtonRa Partners | 28,172 | $1,549,000 | 1.42% |
| Vivo Capital, LLC | 244,375 | $13,441,000 | 1.35% |
| Avidity Partners Management LP | 1,000,000 | $55,000,000 | 1.26% |